PACS Group (NYSE:PACS - Get Free Report) was upgraded by equities researchers at Wall Street Zen from a "buy" rating to a "strong-buy" rating in a research report issued to clients and investors on Saturday, Wall Street Zen reports.
PACS has been the topic of several other reports. Zacks Research cut PACS Group from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, September 9th. JPMorgan Chase & Co. lifted their target price on PACS Group from $47.00 to $58.00 and gave the company an "overweight" rating in a report on Friday, September 4th. Truist Financial reissued a "buy" rating and set a $65.00 target price (up from $62.00) on shares of PACS Group in a research note on Thursday, November 5th. Oppenheimer upped their price target on PACS Group from $48.00 to $57.00 and gave the stock an "outperform" rating in a report on Monday, August 10th. Finally, UBS Group upped their price target on PACS Group from $60.00 to $67.00 and gave the stock a "buy" rating in a report on Thursday, November 5th. Seven research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $62.50.
Read Our Latest Stock Analysis on PACS Group
PACS Group Price Performance
PACS Group stock opened at $43.63 on Friday. The firm has a market cap of $6.92 billion, a PE ratio of 22.37, a price-to-earnings-growth ratio of 1.59 and a beta of -0.14. PACS Group has a 52-week low of $24.61 and a 52-week high of $51.68. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 0.22. The company's 50 day moving average is $45.45 and its two-hundred day moving average is $40.65.
PACS Group (NYSE:PACS - Get Free Report) last issued its quarterly earnings results on Tuesday, November 3rd. The company reported $0.63 EPS for the quarter, beating the consensus estimate of $0.58 by $0.05. The company had revenue of $1.50 billion during the quarter, compared to analysts' expectations of $1.46 billion. PACS Group had a net margin of 4.87% and a return on equity of 31.98%. On average, research analysts expect that PACS Group will post 2.05 EPS for the current fiscal year.
Insider Buying and Selling
In related news, Director Mark Hancock sold 186,696 shares of PACS Group stock in a transaction that occurred on Wednesday, November 4th. The shares were sold at an average price of $50.45, for a total value of $9,418,813.20. Following the completion of the transaction, the director owned 53,318,884 shares in the company, valued at $2,689,937,697.80. The trade was a 0.35% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Joshua Jergensen sold 40,000 shares of the business's stock in a transaction on Wednesday, September 16th. The stock was sold at an average price of $43.13, for a total transaction of $1,725,200.00. Following the transaction, the chief operating officer owned 2,496,320 shares of the company's stock, valued at approximately $107,666,281.60. The trade was a 1.58% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,395,000 shares of company stock worth $64,793,252 over the last 90 days. 70.10% of the stock is owned by insiders.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently made changes to their positions in the business. Zacks Investment Management raised its position in shares of PACS Group by 11.3% during the 3rd quarter. Zacks Investment Management now owns 40,754 shares of the company's stock worth $1,693,000 after acquiring an additional 4,123 shares in the last quarter. Aquatic Capital Management LLC purchased a new stake in PACS Group during the third quarter worth approximately $723,000. Cetera Investment Advisers boosted its holdings in PACS Group by 57.1% in the third quarter. Cetera Investment Advisers now owns 18,201 shares of the company's stock valued at $756,000 after purchasing an additional 6,619 shares in the last quarter. Caxton Associates LLP acquired a new position in PACS Group in the third quarter valued at approximately $289,000. Finally, Bleakley Financial Group LLC boosted its holdings in PACS Group by 46.7% in the third quarter. Bleakley Financial Group LLC now owns 32,604 shares of the company's stock valued at $1,355,000 after purchasing an additional 10,385 shares in the last quarter.
PACS Group Company Profile
(
Get Free Report)
PACS Group, Inc. is a post-acute healthcare provider that operates skilled nursing and rehabilitation facilities. Its services include nursing care, physical and occupational therapy, and support for patients recovering from illness or injury, as well as care for people with ongoing or long-term needs. Founded in 2013, the company has expanded its network of facilities across the United States. Its operations are organized through affiliated entities, with care and services tailored to the needs of residents and patients in the communities it serves.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider PACS Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PACS Group wasn't on the list.
While PACS Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.